Literature DB >> 15883329

Ventriculoperitoneal shunt in patients with leptomeningeal metastasis.

Antonio M P Omuro1, Enrico C Lallana, Mark H Bilsky, Lisa M DeAngelis.   

Abstract

The authors reviewed 37 patients with leptomeningeal metastasis (LM) who required a ventriculoperitoneal shunt (VP shunt) for management of intracranial hypertension. Improvement was seen in 27 (77%) patients; subdural hematoma developed in one and shunt malfunction in three. Median overall survival was 2 months (range 2 days to 3.6 years) after VP shunt placement, but there was no procedure-related mortality. The prognosis of LM remained poor, but VP shunt can be an effective palliative tool when required.

Entities:  

Mesh:

Year:  2005        PMID: 15883329     DOI: 10.1212/01.WNL.0000160396.69050.DC

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

Review 1.  Headache in patients with cancer.

Authors:  Samuel A Goldlust; Jerome J Graber; Dana F Bossert; Edward K Avila
Journal:  Curr Pain Headache Rep       Date:  2010-12

2.  Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis.

Authors:  Seung Hoon Lee; Doo Sik Kong; Ho Joon Seol; Do-Hyun Nam; Jung-Il Lee
Journal:  J Neurooncol       Date:  2011-01-28       Impact factor: 4.130

Review 3.  Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review.

Authors:  Yosef Laviv; Burkhard S Kasper; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2017-03-07       Impact factor: 3.042

4.  A case of leptomeningeal carcinomatosis in advanced gastric adenocarcinoma with controlled peritoneal dissemination.

Authors:  Mikihiro Kano; Jun Hihara; Naoki Hirabayashi; Taijiro Sueda
Journal:  Int Cancer Conf J       Date:  2019-04-13

5.  Gefitinib and a ventriculo-peritoneal shunt to manage carcinomatous meningitis from non-small-cell lung cancer: report of two cases.

Authors:  Tetsuya So; Masaaki Inoue; Yasuhiro Chikaishi; Naohiro Nose; Kenji Sugio; Kosei Yasumoto
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

6.  The Pseudotumor Cerebri Syndrome: A Unifying Pathophysiological Concept for Patients with Isolated Intracranial Hypertension with Neither Mass Lesion Nor Ventriculomegaly.

Authors:  G M Halmagyi; R M Ahmed; I H Johnston
Journal:  Neuroophthalmology       Date:  2014-07-24

7.  Leptomeningeal metastases in the MRI era.

Authors:  J L Clarke; H R Perez; L M Jacks; K S Panageas; L M Deangelis
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

Review 8.  Breast leptomeningeal disease: a review of current practices and updates on management.

Authors:  Nicholas B Figura; Victoria T Rizk; Avan J Armaghani; John A Arrington; Arnold B Etame; Hyo S Han; Brian J Czerniecki; Peter A Forsyth; Kamran A Ahmed
Journal:  Breast Cancer Res Treat       Date:  2019-06-17       Impact factor: 4.872

9.  Malignant ascites after subduroperitoneal shunt in a patient with leptomeningeal metastasis.

Authors:  Min Ho Lee; Jung-Il Lee
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

10.  Leptomeningeal metastases in breast cancer.

Authors:  Brian J Scott; Santosh Kesari
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.